血液系统恶性肿瘤相关蛛网膜下腔出血的研究进展  

Research progress of subarachnoid hemorrhage associated with hematologic malignancies

作　　者：黄燕兰[1] 梁志坚[1] Huang Yanlan;Liang Zhijian(Department of Neurology,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China)

机构地区：[1]广西医科大学第一附属医院神经内科,南宁530021

出　　处：《中国脑血管病杂志》2024年第3期202-206,共5页Chinese Journal of Cerebrovascular Diseases

摘　　要：近年来关于血液系统恶性肿瘤相关颅内出血的研究较为活跃,而对血液系统恶性肿瘤相关蛛网膜下腔出血的认识尚不足。本研究检索了来自PubMed和中国知网数据库关于血液系统恶性肿瘤相关蛛网膜下腔出血的文献,总结了血液系统恶性肿瘤相关蛛网膜下腔出血的临床特点及可能的发病机制。目前对于血液系统恶性肿瘤相关蛛网膜下腔出血仍缺乏有效的防治措施,治疗原则主要在积极治疗原发病的同时为并发症的治疗争取时间,其病死率较高。In recent years,there have been active studies on intracranial hemorrhage associated with hematological malignancies,but the understanding of subarachnoid hemorrhage associated with hematological malignancies is still insufficient.We retrieve from PubMed and China National Knowledge Infrastructure(NCKI),and describes the understanding of hematological malignant tumor related subarachnoid hemorrhage.This article summarizes the clinical characteristics and possible pathogenesis of subarachnoid hemorrhage associated with hematological malignancies.At present,there is a lack of effective prevention and treatment measures for hematological malignant tumor-related subarachnoid hemorrhage,which mainly focuses on the active treatment of the primary disease while saving time for the treatment of complications,and the mortality is high.

关 键 词：卒中 血液肿瘤 恶性 蛛网膜下腔出血 白血病 综述 

分 类 号：R733[医药卫生—肿瘤] R743.35[医药卫生—临床医学]